Product Information
ORLISTAT 120 MG CAPSULE is a generic product labeled by H2-Pharma LLC, priced at $7.0033 per EA under NDC 61269056590. Its NADAC has been published 140 times since Dec 20, 2023.
FDA first approved this application on Apr 23, 1999.
Strength
120 mg/1
Manufacturer
H2-Pharma LLCNDC
61269056590
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ORLISTATApproval Type
Authorized Generic (NDA)
FDA Application
NDA020766FDA Approved
4/23/1999
On Market Since
6/1/2022
Pharmacological Classes
Price Statistics
The NADAC for ORLISTAT 120 MG CAPSULE has been published 140 times since Dec 20, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.0033 per EA |
|---|---|
| All-time high | $7.0033 (Aug 19, 2026) |
| All-time low | $6.7884 (Dec 18, 2024) |
| 52-week high | $7.0033 |
| 52-week low | $6.8388 |
| Median price | $6.8816 |
| Average price | $6.8837 |
| Largest weekly change | -2.4% (May 22, 2024) |
| Weeks tracked | 140 |
| Tracking since | Dec 20, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ORLISTAT 120 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ORLISTAT 120 MG CAPSULE, manufactured by H2-Pharma LLC, is $7.0033 per EA (NDC 61269056590), effective Aug 19, 2026.
How has the price of ORLISTAT 120 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ORLISTAT 120 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 140 weekly CMS publications since Dec 20, 2023.
What are the highest and lowest recorded NADAC prices for ORLISTAT 120 MG CAPSULE?
Since Dec 20, 2023, the NADAC for ORLISTAT 120 MG CAPSULE has ranged from a low of $6.7884 (Dec 18, 2024) to a high of $7.0033 (Aug 19, 2026), with a median of $6.8816 per EA.
Are there cheaper alternatives to ORLISTAT 120 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, XENICAL 120 MG CAPSULE, is $4.5986 per EA — about 34% below ORLISTAT 120 MG CAPSULE.
Who manufactures ORLISTAT 120 MG CAPSULE?
ORLISTAT 120 MG CAPSULE (NDC 61269056590) is labeled by H2-Pharma LLC, and CMS classifies it as a generic product.